Get the Stockscreener App
4.89
9.52%
0.425
Pulmatrix Inc stock is traded at $4.89, with a volume of 14,341.
It is up +9.52% in the last 24 hours and down -19.57% over the past month.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
See More
Previous Close:
$4.465
Open:
$4.5
24h Volume:
14,341
Relative Volume:
0.49
Market Cap:
$17.86M
Revenue:
$11.68M
Net Income/Loss:
$-8.85M
P/E Ratio:
-2.029
EPS:
-2.41
Net Cash Flow:
$-14.61M
1W Performance:
+3.82%
1M Performance:
-19.57%
6M Performance:
-45.18%
1Y Performance:
+138.54%
1-Day Range:
$4.45
$4.89
1-Week Range:
$4.44
$4.90
52-Week Range:
$1.78
$10.40
Pulmatrix Inc Stock (PULM) Company Profile
Name
Pulmatrix Inc
Sector
Industry
Phone
(888) 355-4440
Address
945 CONCORD STREET, FRAMINGHAM, MA
Compare PULM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PULM
Pulmatrix Inc
|
4.89 | 17.20M | 11.68M | -8.85M | -14.61M | -2.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Pulmatrix Inc Stock (PULM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-09-18 | Initiated | H.C. Wainwright | Buy |
Pulmatrix Inc Stock (PULM) Latest News
Pulmatrix Inc. May Stage Comeback if Support HoldsAnalysts Use RSI to Predict NTES’s Next Move2025 EndofYear Setup & Weekly Top Stock Performers List - newsyoung.net
Historical volatility pattern of Pulmatrix Inc. visualized2025 Technical Patterns & Intraday High Probability Alerts - Newser
Is Pulmatrix Inc. trending in predictive chart models2025 Growth vs Value & Risk Managed Investment Entry Signals - Newser
Is Pulmatrix Inc. showing signs of accumulation2025 Retail Activity & High Accuracy Swing Entry Alerts - Newser
Does Pulmatrix Inc. qualify in momentum factor screening2025 Market Outlook & Expert Curated Trade Setups - Newser
What high frequency data says about Pulmatrix Inc.2025 Price Momentum & Weekly High Potential Alerts - Newser
How high can Pulmatrix Inc. stock goJuly 2025 Momentum & Reliable Intraday Trade Alerts - Newser
How moving averages guide Pulmatrix Inc. tradingInsider Selling & Weekly High Return Stock Opportunities - Newser
Detecting price anomalies in Pulmatrix Inc. with AIInflation Watch & Smart Money Movement Alerts - Newser
Price action breakdown for Pulmatrix Inc.July 2025 Rallies & Technical Analysis for Trade Confirmation - Newser
Tools to assess Pulmatrix Inc.’s risk profileWeekly Stock Report & Low Volatility Stock Recommendations - Newser
Pulmatrix Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingEarnings Overview Report & Community Consensus Stock Picks - Newser
Pulmatrix Inc.’s volatility index tracking explainedDollar Strength & Safe Investment Capital Preservation Plans - Newser
Backtesting results for Pulmatrix Inc. trading strategiesJuly 2025 Institutional & Real-Time Stock Movement Alerts - Newser
How do insiders feel about Pulmatrix Inc.2025 Technical Overview & Daily Volume Surge Signals - thegnnews.com
Building trade automation scripts for Pulmatrix Inc.CEO Change & Stock Market Timing Techniques - Newser
Forecasting Pulmatrix Inc. price range with options dataExit Point & Risk Controlled Swing Alerts - Newser
Will Pulmatrix Inc. benefit from AI trendsJuly 2025 PreEarnings & Verified Short-Term Trading Plans - mustnews.co.kr
Applying sector rotation models to Pulmatrix Inc.2025 Volatility Report & Real-Time Chart Pattern Alerts - Newser
Has Pulmatrix Inc. found a price floorJuly 2025 Review & Free Technical Pattern Based Buy Signals - Newser
When is the best time to exit Pulmatrix Inc.July 2025 Trends & Community Verified Trade Signals - Newser
Pulmatrix (PULM) Q2 Revenue Falls 100% - AOL.com
How high can Pulmatrix Inc. stock price go in 20252025 Top Decliners & Entry Point Confirmation Alerts - Newser
What is the Moat Score of Pulmatrix Inc.2025 Price Momentum & Daily Profit Maximizing Trade Tips - thegnnews.com
Measuring Pulmatrix Inc.’s beta against major indicesEarnings Overview Summary & Step-by-Step Swing Trade Plans - Newser
Buy Signal for Pulmatrix Inc. Stock Key Technical Indicators to WatchWeekly Trade Review & AI Driven Price Predictions - Newser
Short Term Trend Reversal in Pulmatrix Inc. PossibleJuly 2025 Trends & Verified Momentum Stock Watchlist - sundaytimes.kr
Pulmatrix Inc. Forms Double Bottom Pattern — Eyes on BreakoutJuly 2025 Catalysts & Weekly Return Optimization Plans - newsyoung.net
What analysts say about Pulmatrix Inc. stock outlook2025 Price Targets & Free Verified High Yield Trade Plans - Newser
Pulmatrix Inc. stock retracement – recovery analysisSwing Trade Entry and Exit Point Analysis - Newser
Pulmatrix Inc. Ranks High in Smart Money TrackerWatchlist for Smart Swing Trading Updated - 선데이타임즈
How Pulmatrix Inc. stock performs during market volatilityWatchlist Generator With Real-Time Entry - Newser
Using Ichimoku Cloud for Pulmatrix Inc. technicalsRisk Managed Watchlist with Breakout Picks - Newser
Tick level data insight on Pulmatrix Inc. volatilityFree Day Trading Signals With High Precision - Newser
Pulmatrix Inc Stock (PULM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):